Modes and duration
- Full-time: 1 year
Programme start date
Tuition Fees (2016/17)
- £13,370 (FT)
- £25,140 (FT)
A minimum of an upper second-class Bachelor's degree from a UK university in a relevant discipline such as life sciences or medicine or an overseas qualification of an equivalent standard.
English Language Requirements
If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency.
The English language level for this programme is: Good
Further information can be found on our English language requirements page.
Country-specific information, including details of when UCL representatives are visiting your part of the world, can be obtained from the International Students website.
International applicants can find out the equivalent qualification for their country by selecting from the list below.
Select your country:
This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students learn about the approaches taken to predict, detect, monitor and treat cancer, alongside the cutting-edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies.
Students undertake modules to the value of 180 credits.
The programme consists of two core modules (60 credits), four specialist modules (60 credits) and a research project (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months) is offered.
A Postgraduate Certificate (60 credits, full-time 12 weeks) is offered.
- Basic Biology and Cancer Genetics
- Cancer Therapeutics
- Behavioural Science and Cancer
- Biomarkers in Cancer
- Cancer Clinical Trials
- Haematological Malignancies and Gene Therapy
All MSc students undertake a laboratory project, clinical trials project or systems biology/informatics project, which culminates in a 10,000–12,000 word dissertation and an oral research presentation.
Teaching and Learning
Students develop their knowledge and understanding of cancer through lectures, self-study, database mining, wet-lab based practicals, clinical trial evaluations, laboratory training, assigned reading and self-learning. Each taught module is assessed by an unseen written examination and/or coursework. The research project is assessed by the dissertation (75%) and oral presentation (25%).
Scholarships relevant to this department are displayed (where available) below. For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website.
- £5,000 / £25,000 (One year)
- UK, EU, Overseas students
More scholarships are listed on the Scholarships and Funding website
The knowledge and skills developed will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating a PhD or medical studies in cancer.
Top career destinations for this degree
- PhD student, University of Zurich (2014)
- Research Technician, University of Bath (2014)
- Medical Science Liaison in breast cancer, Roche- Beijing (2014)
- Clinical Trials Co-ordinator, Cyprus (2014)
- PhD student, EMBL (2014)
Skills include critical evaluation of scientific literature, experimental planning and design interpretation of data and results, presentation/public speaking skills, time management, working with a team, working independently and writing for various audiences.
Why study this degree at UCL?
UCL is one of Europe's largest and most productive centres of biomedical science, with an international reputation for leading basic, translational and clinical cancer research.
The UCL Cancer Institute brings together scientists from various disciplines to synergise multi-disciplinary research into cancer, whose particular areas of expertise include: the biology of leukaemia, the infectious causes of cancer, the design of drugs that interact with DNA, antibody-directed therapies, the molecular pathology of cancer, signalling pathways in cancer, epigenetic changes in cancer, gene therapy, cancer stem cell biology, early phase clinical trials, and national and international clinical trials in solid tumours and blood cancers.
Student / staff ratios › 224 staff including 74 postdocs › 32 taught students › 89 research students
Department: Cancer Institute
"In addition to UCL and UCL Hospitals, London in general has all you need in terms of basic science and resources as well as clinical oncologists who want to team up with basic scientists to develop potent translational programs in cancer, autoimmunity, genetic diseases and so on."
Dr Sergio QuezadaProgrammes in the Faculty of Medical Sciences and in the Master’s programmes in Cancer
"UCL and the UCL Cancer Institute gave me the opportunity to meet and maintain contact with important and established people in my field of interest, both in academia and industry. I also had the chance to meet invited scientists from the UK and other universities from around the world."
Dimitra GeorgopoulouCancer MSc (2010)
"There have been many things that have been impressive in the programme. For the core module we had an extremely wide variety of lecturers who were at the cutting-edge of their field which gave a largely in depth-look at the field of cancer research as a whole. The summer lab project has been a great opportunity to develop current lab skills and learn new ones as well as actually doing something worthwhile; additionally, at least in my experience, everyone in the lab seems to go out of their way to help and, instead of thinking you're just getting in everyone's way, it feels like you're a part of the lab and people are interested in the work that you're doing."
Ben DraperCancer MSc
Application and next steps
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
Who can apply?
The programme is designed for those with qualifications in life sciences, scientists, clinicians, and other healthcare professionals including individuals from the pharmaceutical and biotech industries. The knowledge and transferable skills developed are suitable for those in an industrial or healthcare setting, and for students contemplating further PhD or medical studies.
- All applicants
- 29 July 2016
For more information see our Applications page.Apply now
What are we looking for?When we assess your application we would like to learn:
- why you want to study this programme at graduate level
- why you want to study this programme at UCL
- what particularly attracts you to this programme
- how your academic and professional background meets the demands of this programme
- where you would like to go professionally with your degree